U.S. Insurance Stock News

NasdaqGM:SPWR
NasdaqGM:SPWRElectrical

SunPower (SPWR) FY 2025 Loss Deepens Bear Narratives On Profitability

SunPower FY 2025 earnings snapshot SunPower (SPWR) has just wrapped up FY 2025 with Q4 revenue of about US$79.7 million and a basic EPS loss of US$0.14, setting a cautious tone around profitability even as top line activity continues. Over the recent quarters, revenue has moved from US$88.7 million in Q4 2024 to US$82.7 million in Q1 2025, US$67.5 million in Q2 2025 and US$70.0 million in Q3 2025, before reaching US$79.7 million in Q4. EPS shifted from a profit of US$0.58 in Q4 2024 to mixed...
NYSE:KMX
NYSE:KMXSpecialty Retail

CarMax (KMX) Margin Compression And EPS Loss Challenge Bullish Growth Narratives

CarMax FY 2026 earnings snapshot CarMax (KMX) has just closed out FY 2026 with fourth quarter revenue of US$6.4b, a basic EPS loss of US$0.85 and net income of US$120.7m in the red, alongside a 2% same store sales decline. This puts a clear spotlight on margins. Over the year, quarterly revenue has moved from US$8.0b in Q1 2026 to US$6.4b in Q4 2026, while basic EPS has ranged from US$1.38 in Q1 to a loss of US$0.85 in Q4. Trailing twelve month EPS stands at US$1.68 and net income at...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Cintas (CTAS) Valuation Check After Recent Share Price Pullback

Cintas (CTAS) is back on investors' radar after recent share price moves, with the stock down over the past month and past 3 months. This has prompted a closer look at current valuation and business performance. See our latest analysis for Cintas. The recent pullback stands out against a longer record, with a 30 day share price return showing an 8.45% decline and a year to date share price return showing a 4.55% decline. Meanwhile, the 3 year total shareholder return of 59.48% and 5 year...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Is It Too Late To Consider Sterling Infrastructure (STRL) After A 225% One Year Surge?

If you are wondering whether Sterling Infrastructure's current share price still offers value after a strong run, the key is to look closely at what the market might already be pricing in. The stock closed at US$456.08, with returns of 7.7% over 7 days, 9.2% over 30 days, 42.9% year to date and 224.8% over 1 year. This naturally raises questions about how much optimism is now embedded in the price and whether risk perceptions have shifted. Recent attention around Sterling Infrastructure has...
NYSE:PGR
NYSE:PGRInsurance

Progressive (PGR) Combined Ratio Of 87.4% Tests Bearish Margin Narratives

Progressive (PGR) opened 2026 with solid momentum, coming off Q4 2025 revenue of about US$22.7b and basic EPS of US$5.03, backed by trailing 12 month figures of US$87.6b in revenue and EPS of US$19.29, alongside year over year earnings growth of 33.6%. Over the past reported periods, revenue has moved from roughly US$20.3b in Q4 2024 to US$22.7b in Q4 2025, while quarterly EPS ranged between about US$3.99 and US$5.42. This sets up a story where margin trends and underwriting performance take...
NasdaqCM:SMID
NasdaqCM:SMIDBasic Materials

Smith Midland (SMID) 62.9% Earnings Growth Reinforces Bullish Narratives

Smith-Midland (SMID) has wrapped up FY 2025 with fourth quarter revenue of US$23.1 million and net income of US$2.1 million, translating to EPS of US$0.40 and rounding out a trailing 12 month EPS figure of US$2.36 on revenue of US$93.4 million. Over recent quarters the company has seen revenue move from US$18.5 million in Q4 FY 2024 to US$23.1 million in Q4 FY 2025, while quarterly EPS over the same period went from US$0.26 to US$0.40. This gives a clear sense of how the top line and per...
NYSE:FMC
NYSE:FMCChemicals

A Look At FMC (FMC) Valuation After EU Approval For Isoflex Active

FMC (FMC) is in focus after announcing European Union regulatory approval for its herbicide molecule Isoflex active. This marks a key step toward commercializing products across more than 55 million hectares of major crops. See our latest analysis for FMC. FMC's recent Isoflex active approval comes after a sharp 26.23% 1 month share price return and 21.48% year to date gain. However, the 1 year total shareholder return of 51.26% and 5 year total shareholder return of 82.25% indicate that...
NYSE:PNR
NYSE:PNRMachinery

Assessing Pentair (PNR) Valuation After Mixed Short And Long Term Share Performance

Why Pentair is on investors’ radar today Pentair (PNR) has attracted fresh attention after recent trading left the shares with mixed short term performance, including a 3 month return of about a 17% decline and a 1 year total return of 10.6%. See our latest analysis for Pentair. The recent 17.4% 3 month share price decline, alongside a 16.2% negative year to date share price return, contrasts with Pentair’s 10.6% 1 year total shareholder return. This suggests fading short term momentum...
NasdaqGS:SHOO
NasdaqGS:SHOOLuxury

Is Steven Madden (SHOO) Pricing Reflect Its Strong One Year Rally And DCF Upside Potential

If you are wondering whether Steven Madden's current share price reflects its underlying worth, or if the market is getting ahead of itself, this article walks through the key signals you can use to judge value for yourself. The stock closed at US$38.38, with returns of 3.1% over 7 days, 19.0% over 30 days, a 9.1% decline year to date, and 101.6% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage has focused on Steven...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

A Look At Zscaler (ZS) Valuation As Earnings Approach And Shares Trail The Broader Market

Zscaler (ZS) is back in focus after its shares lagged the broader market over the past month, drawing attention to the upcoming earnings report and what fresh analyst estimate revisions might signal. See our latest analysis for Zscaler. At around US$131 per share, Zscaler has seen strong short term volatility, with a 1 day share price return of 6.79% alongside a 30 day share price return decline of 14.76% and a 1 year total shareholder return decline of 35.42%. This suggests momentum has been...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Valuation Check As New Sol De Janeiro Partnership Expands Beauty Offering

Urban Outfitters (URBN) has announced a new retail partnership with beauty brand Sol de Janeiro, expanding its beauty and wellness assortment and sharpening its focus on categories closely followed by Gen Z shoppers. See our latest analysis for Urban Outfitters. The new Sol de Janeiro tie up lands at a time when Urban Outfitters’ share price has been choppy in the short term, with a 1 day share price return of 3.57% and a 30 day share price return of 5.64%. Yet year to date the share price...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

A Look At LifeStance Health Group (LFST) Valuation As New Outcomes Data Highlights Care Model Effectiveness

Clinical outcomes data as a potential input for investors LifeStance Health Group (LFST) released new clinical outcomes data covering roughly 180,000 patients across 33 states, reporting clinically significant symptom improvements in anxiety and depression that may interest investors tracking quality of care metrics. According to the company, 79% of patients treated for anxiety and 73% of those treated for depression showed clinically significant improvements based on GAD-7 and PHQ-9...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Is Navan (NAVN) Fairly Priced After Recent Nasdaq Debut And Sharp Share Price Rebound

Wondering if Navan at around US$14.43 is a genuine opportunity or just riding a short term buzz? This article focuses squarely on what that price might mean for underlying value. The stock has recently moved sharply, with a 7 day return of 11.5% and a 30 day return of 63.8%, even as the year to date return sits at an 11.2% decline. Recent coverage has highlighted Navan as a travel and expense platform that drew attention through its Nasdaq listing and subsequent trading activity, which has...
NYSE:SMR
NYSE:SMRElectrical

Reassessing NuScale Power (SMR) After Recent Share Price Swings And DCF Valuation Results

Wondering whether NuScale Power's current share price really reflects what you are getting for your money? This breakdown aims to help you weigh up the stock's value with clear, structured checks. NuScale Power recently closed at US$11.71, with returns of 18.8% over the last 7 days, a 2.2% decline over 30 days, a 28.2% decline year to date, and a 19.2% decline over 1 year, set against gains of 32.3% over 3 years and 16.9% over 5 years. These mixed returns have kept NuScale Power in focus, as...
NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Earnings Beat, Higher Guidance, Bigger Credit Line Might Change The Case For Investing In LINC

In early 2026, Lincoln Educational Services reported a strong fourth quarter with revenue surpassing analyst expectations by 6.9% and raised its full-year revenue guidance, while also amending and restating its revolving credit facility to increase available funding from US$60,000,000 to US$125,000,000 through April 2031. Together, the earnings beat, upgraded outlook, and expanded credit facility underline how operational momentum and added financial flexibility may support Lincoln...
NYSE:HAL
NYSE:HALEnergy Services

How Halliburton’s Vaca Muerta Electric Frac Deal At Halliburton (HAL) Has Changed Its Investment Story

On 13 April 2026, Halliburton announced an exclusive, multi-year multibillion-dollar contract from YPF to deliver bundled unconventional completions services in Argentina’s Vaca Muerta shale, including the first international deployment of its ZEUS electric fracturing and OCTIV digital fracturing technologies. This deal not only deepens Halliburton’s role in one of the world’s largest shale resources outside North America, it also showcases how its electrified and automated fracturing...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Assessing Nebius Group (NBIS) Valuation After Major Meta AI Contract And Nvidia Investment

Nebius Group (NBIS) is back in focus after reports that it is in talks to acquire AI21 Labs, adding a potential model and agent platform deal to its large AI infrastructure contracts. See our latest analysis for Nebius Group. The AI21 Labs talks come on top of a powerful run, with Nebius shares around $166.77 and a 7 day share price return of 33.42% on top of an 85.40% year to date gain. The 1 year total shareholder return is roughly 7x and the 5 year total shareholder return is also very...
NYSE:VLTO
NYSE:VLTOCommercial Services

Is Veralto’s Mixed Quarter and Softer EPS Outlook Altering The Investment Case For VLTO?

Recently, Veralto, the 2023 Danaher spin-off focused on water analytics and treatment, reported past-quarter revenues of US$1.40 billion, up 3.8% year on year, beating earnings-per-share estimates but issuing next-quarter EPS guidance below analyst expectations. This combination of revenue growth, an earnings beat, and more cautious forward EPS guidance highlights how Veralto is balancing current demand with a measured outlook on profitability. With Veralto pairing revenue growth and an EPS...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley (MS) Margin Gain And EPS Surge Test Bullish Narratives Heading Into Q1 2026

Morgan Stanley (MS) has just wrapped up Q1 2026 with investors looking closely at how recent revenue and EPS trends stack up against its premium share price of US$191.62 and a trailing net profit margin of 23.1%. Over the last six reported quarters, total revenue has moved from US$15.3 billion in Q3 2024 to US$17.9 billion in Q4 2025, while quarterly EPS shifted from US$1.91 to US$2.72 across the same stretch, and trailing twelve month EPS reached US$10.32. With earnings over the past year...
NYSE:HIMS
NYSE:HIMSHealthcare

Is Hims & Hers (HIMS) Using AI Upgrades To Cement A Durable Virtual Care Moat?

Hims & Hers Health recently announced that it would report its first-quarter 2026 results on May 11 and that management would speak at the Evercore TMT Conference, while also outlining platform upgrades, deeper artificial intelligence integration, and expanded partnerships for FDA-approved medications and advanced diagnostic services. By adding AI-enhanced care, multi-cancer early detection testing, and broader access to prescription treatments, the company is pushing further into...
NYSE:ABR
NYSE:ABRMortgage REITs

A Look At Arbor Realty Trust’s Valuation As Earnings Expectations And Cautious Analyst Sentiment Shape The Outlook

Why Arbor Realty Trust (ABR) Is Back on Investors’ Radar Arbor Realty Trust (ABR) is drawing attention after a recent share move ahead of its upcoming earnings report, where analysts are expecting a 42.86% EPS drop and slightly lower revenue. See our latest analysis for Arbor Realty Trust. The recent 1 day share price return of 1.54% and 7 day return of 5.46% suggest traders are positioning ahead of earnings. However, the 1 year total shareholder return decline of 16.52% and flat year to date...
NYSE:CWK
NYSE:CWKReal Estate

Cushman And Wakefield Balances Sotheby’s Lawsuit With New Las Vegas Mandate

Cushman & Wakefield (NYSE:CWK) has filed a lawsuit against Sotheby’s, seeking an alleged unpaid $10 million commission tied to the Weill Cornell real estate transaction. The firm has also been appointed to manage The Ellison, a large multifamily community in Las Vegas. These developments come alongside recent share price levels of $13.89 and a 70.4% return over the past year. For investors watching NYSE:CWK, these moves highlight both legal and operational developments. The commission...
NYSE:VAL
NYSE:VALEnergy Services

Assessing Valaris (VAL) Valuation After Petrobras Extension And New Halliburton PETRONAS Alliance

Why Valaris Stock Is Back in Focus Valaris (VAL) is back on investor radars after two contract announcements: a multiyear extension with Petrobras for the VALARIS DS 4 drillship offshore Brazil, and a new collaboration with Halliburton and PETRONAS Suriname. See our latest analysis for Valaris. Even after the Petrobras extension and new Suriname collaboration, the share price has eased in the last week. However, the 90 day share price return of 67.53% and 1 year total shareholder return of...